We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current EPRX market cap is 78.05M. The company's latest EPS is CAD -1.0344 and P/E is -3.82.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | ||
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -5.07M | -8.8M | -4.79M | -6.46M | -10.51M |
| Net Income | -4.66M | -8.82M | -5.04M | -7.75M | -11.34M |
| Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 |
| Operating Income | -2.25M | -18.68M | -23.2M | -27.85M |
| Net Income | -4.01M | -22.99M | -23.26M | -28.22M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | ||
| Total Assets | 31.45M | 25.88M | 19.88M | 20.35M | 34.35M |
| Total Liabilities | 12.37M | 14.51M | 12.82M | 14.66M | 19.29M |
| Total Equity | 19.08M | 11.36M | 7.06M | 5.69M | 15.06M |
| Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Assets | 1.45M | 31.22M | 25.88M | 20.27M |
| Total Liabilities | 23.12M | 11.67M | 14.51M | 19.37M |
| Total Equity | -21.66M | 19.55M | 11.36M | 892k |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | ||
| Operating | -13.49M | -18.78M | -6.16M | -11.86M | -19.81M |
| Investing | -9.21M | 8.7M | -11k | -19k | -32k |
| Financing | 13.16M | 13.52M | 260k | 6.27M | 28.31M |
| Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Operating | -404k | -14.64M | -18.78M | -20.68M |
| Investing | 25k | -14.45M | 8.7M | -73k |
| Financing | -627k | 49.92M | 13.52M | 21.01M |
| Market Cap | 78.05M |
| Price to Earnings Ratio | -3.82 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 5.57 |
| Price to Book Ratio | 120.81 |
| Dividend Yield | - |
| Shares Outstanding | 27.28M |
| Average Volume (1 week) | 6.3k |
| Average Volume (1 Month) | 18.35k |
| 52 Week Change | -19.41% |
| 52 Week High | 3.55 |
| 52 Week Low | 2.48 |
| Spread (Intraday) | 1.9 (61.89%) |
| Company Name | Eupraxia Pharmaceuticals Inc |
| Address |
201 - 2067 cadboro bay road victoria, british columbia V8R 5G4. |
| Website | https://www.eupraxiapharma.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
